Brain Tumour
Medical Classification: Intracranial Neoplasm (Benign & Malignant)
An abnormal growth of cellular tissue within the rigid cranial vault, requiring precise neurosurgical evaluation, imaging assessment, and individualized care.
Understanding Brain Tumour
A brain tumour develops when cells inside the brain or surrounding meninges replicate abnormally. Because the bony skull cannot expand, any space-occupying lesion can increase intracranial pressure and impinge upon vital neural structures. Brain tumours can be primary (originating in brain tissue or coverings, such as meningiomas and gliomas) or secondary (metastatic from other sites).
Common Symptoms & Warning Signs
Etiology & Underlying Causes
- Genetic factors and cellular mutations affecting growth-regulating genes
- Prior exposure to high-dose ionizing radiation (rare)
- Benign neoplastic transformation of meningeal or nerve sheath cells (e.g. meningiomas, schwannomas)
- Secondary spread from primary systemic cancers via the bloodstream
Diagnostic Evaluation & Imaging Protocols
Contrast-Enhanced Magnetic Resonance Imaging (CEMRI Brain) – Gold standard for anatomical definition and tissue characterization
MR Spectroscopy & Diffusion Tensor Imaging (DTI) – Evaluates cellular metabolites and relationship to critical speech/motor white matter tracts
High-Resolution Computed Tomography (CT Scan) – Evaluates bony involvement, calcification, and acute hemorrhage
Histopathological & Molecular Examination – Definite post-biopsy or post-resection diagnosis guiding adjuvant oncological therapies
Treatment Pathways
Individualized pathways based on neurological severity, imaging correlation, and patient lifestyle.
Microsurgical Resection
Precision craniotomy utilizing the operating microscope and neuronavigation to excise maximum tumor volume while preserving neurological function.
Awake Craniotomy with Cortical Mapping
For tumors located within eloquent motor or language cortex, enabling continuous clinical testing during lesion removal.
Stereotactic Biopsy
Minimally invasive needle sampling for deep, diffuse, or non-resectable lesions requiring tissue diagnosis.
Multidisciplinary Adjuvant Care
Coordinated radiation oncology, stereotactic radiosurgery (SRS/Gamma Knife), and chemotherapy based on tumor molecular genetics.
When to Seek Urgent Neurosurgical Evaluation
Seek urgent medical attention if experiencing new persistent headaches accompanied by morning vomiting, unexpected seizures, sudden weakness in limbs, or speech difficulties.
Frequently Asked Questions
Are all brain tumours fatal or malignant?
No. A large proportion of brain tumours are benign (non-cancerous), such as meningiomas, pituitary adenomas, and acoustic neuromas. With timely surgical removal, many benign lesions are cured or effectively controlled for decades.
What determines whether a brain tumour can be surgically removed?
Surgical feasibility depends on tumor location (surface vs. deep brainstem), proximity to major blood vessels, patient general health, and whether the lesion is well-circumscribed or diffuse.
Clinical Opinion for Brain Tumour
Schedule an in-depth clinical consultation with Dr. Sanatan Satapathy at MAX Super Speciality Hospital, Bhubaneswar.
Request OPD AppointmentRelated Surgical Discipline
Learn more about surgical corridors and technology for this condition:
Brain Surgery & Microneurosurgery* Medical Disclaimer: This guide is intended solely for patient educational awareness. It does not replace individualized diagnostic evaluation by a certified physician.
Your Journey Towards Better Neurological Care Starts Here.
Schedule a consultation to discuss your symptoms, concerns and available treatment options with Dr. Sanatan Satapathy.